Print Page

Letters to Healthcare Providers
 
Update to information on psychiatric disorders for chloroquine and hydroxychloroquine (Letter to Healthcare Professionals)
 
 
 
Attachment:
  1. Update to information on psychiatric disorders for chloroquine and hydroxychloroquine  
Related Information:
The United Kingdom: Hydroxychloroquine and chloroquine: increased risk of cardio... Posted 2022-02-16
European Union: Update to information on psychiatric disorders for chloroquine a... Posted 2020-11-28
The United States: FDA cautions against use of hydroxychloroquine or chloroquine... Posted 2020-06-16
Singapore: Use of hydroxychloroquine (Plaquenil®) in the context of COVID 19: Ri... Posted 2020-06-03
European Union: COVID-19: reminder of the risks of chloroquine and hydroxychloro... Posted 2020-05-30
Canada: Chloroquine and hydroxychloroquine can have serious side effects. These ... Posted 2020-04-27
The United States: Coronavirus (COVID-19) Update: FDA Reiterates Importance of C... Posted 2020-04-25
European Union: COVID-19: reminder of risk of serious side effects with chloroqu... Posted 2020-04-24
Health Sciences Authority: Risk of hypoglycaemia associated with hydroxychloroqu... Posted 2014-12-29
Singapore: Risk of hypoglycaemia associated with hydroxychloroquine or chloroqui... Posted 2014-12-27
 
back